扶桑薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/08/04 | 2,013 | 2,034 | 2,012 | 2,018 | +5 | +0.2% | 3,500 |
2023/08/03 | 2,041 | 2,050 | 2,003 | 2,013 | -43 | -2.1% | 9,000 |
2023/08/02 | 2,070 | 2,074 | 2,050 | 2,056 | -14 | -0.7% | 5,300 |
2023/08/01 | 2,062 | 2,074 | 2,052 | 2,070 | +8 | +0.4% | 7,500 |
2023/07/31 | 2,073 | 2,077 | 2,053 | 2,062 | +39 | +1.9% | 12,100 |
2023/07/28 | 2,067 | 2,067 | 2,023 | 2,023 | -33 | -1.6% | 16,100 |
2023/07/27 | 2,058 | 2,072 | 2,056 | 2,056 | -5 | -0.2% | 5,700 |
2023/07/26 | 2,050 | 2,092 | 2,050 | 2,061 | +11 | +0.5% | 15,100 |
2023/07/25 | 2,065 | 2,069 | 2,050 | 2,050 | -4 | -0.2% | 4,700 |
2023/07/24 | 2,045 | 2,062 | 2,042 | 2,054 | +12 | +0.6% | 7,600 |
2023/07/21 | 2,022 | 2,048 | 2,022 | 2,042 | +20 | +1% | 4,600 |
2023/07/20 | 2,053 | 2,053 | 2,009 | 2,022 | -26 | -1.3% | 22,400 |
2023/07/19 | 2,016 | 2,048 | 2,016 | 2,048 | +44 | +2.2% | 17,900 |
2023/07/18 | 1,997 | 2,021 | 1,997 | 2,004 | +13 | +0.7% | 7,700 |
2023/07/14 | 1,993 | 2,010 | 1,987 | 1,991 | -1 | -0.1% | 6,900 |
2023/07/13 | 2,010 | 2,010 | 1,987 | 1,992 | +1 | +0.1% | 7,200 |
2023/07/12 | 2,008 | 2,008 | 1,985 | 1,991 | +8 | +0.4% | 9,600 |
2023/07/11 | 2,006 | 2,010 | 1,983 | 1,983 | +6 | +0.3% | 10,600 |
2023/07/10 | 1,988 | 2,010 | 1,977 | 1,977 | -11 | -0.6% | 11,300 |
2023/07/07 | 2,013 | 2,013 | 1,988 | 1,988 | -23 | -1.1% | 6,500 |
2023/07/06 | 1,996 | 2,011 | 1,992 | 2,011 | +11 | +0.6% | 4,700 |
2023/07/05 | 1,981 | 2,007 | 1,981 | 2,000 | -6 | -0.3% | 6,200 |
2023/07/04 | 2,019 | 2,019 | 1,991 | 2,006 | -3 | -0.1% | 9,300 |
2023/07/03 | 2,006 | 2,023 | 2,003 | 2,009 | +3 | +0.1% | 3,900 |
2023/06/30 | 1,994 | 2,006 | 1,984 | 2,006 | +1 | ±0% | 9,100 |
2023/06/29 | 2,014 | 2,015 | 1,993 | 2,005 | -11 | -0.5% | 4,300 |
2023/06/28 | 2,007 | 2,018 | 1,997 | 2,016 | +29 | +1.5% | 5,600 |
2023/06/27 | 2,000 | 2,000 | 1,974 | 1,987 | -8 | -0.4% | 7,300 |
2023/06/26 | 1,990 | 2,003 | 1,980 | 1,995 | +5 | +0.3% | 6,900 |
2023/06/23 | 1,995 | 2,010 | 1,981 | 1,990 | -5 | -0.3% | 6,000 |
2023/06/22 | 2,004 | 2,024 | 1,990 | 1,995 | -18 | -0.9% | 11,300 |
2023/06/21 | 2,012 | 2,027 | 2,009 | 2,013 | -18 | -0.9% | 6,800 |
2023/06/20 | 2,021 | 2,038 | 2,007 | 2,031 | -4 | -0.2% | 9,700 |
2023/06/19 | 2,045 | 2,045 | 2,022 | 2,035 | +17 | +0.8% | 7,000 |
2023/06/16 | 2,009 | 2,021 | 1,996 | 2,018 | +9 | +0.4% | 13,000 |
2023/06/15 | 2,020 | 2,034 | 2,009 | 2,009 | -23 | -1.1% | 7,800 |
2023/06/14 | 1,986 | 2,037 | 1,986 | 2,032 | +26 | +1.3% | 12,100 |
2023/06/13 | 1,973 | 2,007 | 1,973 | 2,006 | +25 | +1.3% | 7,500 |
2023/06/12 | 1,986 | 1,995 | 1,981 | 1,981 | +15 | +0.8% | 1,900 |
2023/06/09 | 1,978 | 1,985 | 1,966 | 1,966 | +14 | +0.7% | 8,600 |
2023/06/08 | 1,960 | 1,975 | 1,951 | 1,952 | -9 | -0.5% | 8,000 |
2023/06/07 | 1,994 | 1,994 | 1,960 | 1,961 | -24 | -1.2% | 7,900 |
2023/06/06 | 1,966 | 1,993 | 1,966 | 1,985 | ±0 | ±0% | 2,000 |
2023/06/05 | 1,976 | 2,002 | 1,976 | 1,985 | +34 | +1.7% | 7,700 |
2023/06/02 | 1,933 | 1,962 | 1,933 | 1,951 | +13 | +0.7% | 3,900 |
2023/06/01 | 1,922 | 1,954 | 1,922 | 1,938 | +16 | +0.8% | 6,700 |
2023/05/31 | 1,952 | 1,989 | 1,922 | 1,922 | -53 | -2.7% | 19,000 |
2023/05/30 | 1,990 | 2,000 | 1,975 | 1,975 | -30 | -1.5% | 7,000 |
2023/05/29 | 1,994 | 2,016 | 1,985 | 2,005 | -9 | -0.4% | 9,500 |
2023/05/26 | 2,022 | 2,038 | 2,000 | 2,014 | -14 | -0.7% | 5,900 |
201~
250
件表示中 / 3467件
類似銘柄と比較する
現在ご覧いただいている「扶桑薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
扶桑薬 | 229,900円 | +2.9% | +23.1% | 3.48% | 11.56倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
ステムリム | 46,300円 | -14.9% | -31.0% | 0.00% | 189.75倍 | 3.32倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
セルソース | 127,500円 | +19.0% | -13.1% | 0.39% | 35.12倍 | 4.11倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
大幸薬品 | 36,800円 | +11.1% | - | 0.00% | 33.58倍 | 2.74倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
ヘリオス | 15,800円 | +395.9% | - | 0.00% | - | 3.69倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
市場注目の銘柄
チャート関連のコラム